| ID | Name | CAS | Data |
log10WS |
| 32-611-7 |
Prosta-5,11-dien-1-oic acid, 9-oxo-11,15-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,11«alpha»,13E,15S)-
|
39003-20-8 |
3 | -5.38 |
| 32-772-9 |
7H-imidazo[4,5-d]-v-triazin-4-ol, 7-butyl-, (keto form)
|
|
3 | -2.42 |
| 33-821-3 |
Androst-5-ene-3«beta»,17«beta»-diol-16-one, TMS
|
|
3 | -6.06 |
| 34-142-6 |
4,4'-Bis(2-amino-1-naphthylazo)-2,2'-stilbene disulfonic acid
|
5437-12-7 |
3 | -5.84 |
| 37-009-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
3 | -7.31 |
| 37-448-4 |
1-«beta»,3-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
3 | -6.94 |
| 38-365-5 |
5-(3-Dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, hydrochloride
|
|
3 | -4.52 |
| 39-046-8 |
3-(4-Anilino-1-naphthylazo)-2,7-naphthalene disulfonic acid
|
57322-42-6 |
3 | -4.41 |
| 39-949-6 |
2,4-Imidazolidinedione, 5,5-diphenyl-1,3-bis(trimethylsilyl)-
|
|
3 | -4.66 |
| 41-507-3 |
2-(2,6-Dioxo-3-piperidyl)isoindoline-1,3-dione, N-trimethylsilyl-
|
|
3 | -2.59 |
| 42-582-9 |
5«beta»-Androstan-3«alpha»,11«beta»-diol-17-one (Androsterone), MO-3-mono-TMS
|
|
3 | -4.44 |
| 43-527-9 |
3«alpha»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | -7.02 |
| 44-136-2 |
1-(2-Chloro-3-(1-[(cyclohexylamino)carbonyl]-2-oxohydrazino)propyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine
|
33024-51-0 |
3 | -4.68 |
| 44-687-1 |
Phenothiazine, 2-chloro-10-(3-dimethylaminopropyl)-, cmpd with o-(p-hydroxybenzoyl)benzoic acid (1 to 1)
|
|
3 | -6.58 |
| 45-414-2 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
3 | -5.61 |
| 45-604-1 |
7«alpha»-hydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
3 | -6.58 |
| 45-797-8 |
3«beta»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | -7.02 |
| 45-936-3 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, MO-TMS, (syn,anti)
|
|
3 | -6.01 |
| 46-349-4 |
3«alpha»,6«beta»,7«beta»-Trihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | -6.81 |
| 46-758-0 |
Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, semicarbazone
|
3428-71-5 |
3 | -2.29 |
| 47-312-3 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,12-«alpha»-trihydroxy, methyl ester, TMS
|
|
3 | -7.02 |
| 47-494-2 |
24-Nor-3«alpha»,7«alpha»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | -6.25 |
| 47-980-2 |
5«alpha»-Androstane-2«beta»,3«alpha»,17«beta»-triol, TMS
|
|
3 | -6.85 |
| 48-928-9 |
3«beta»,16«alpha»,17«alpha»-Tris(trimethylsiloxy)androst-5-ene
|
25876-85-1 |
3 | -6.40 |
| 53-221-7 |
2-Chloro-10-(3'-dimethylaminopropyl)-5,5-phenothiazinedioxide, hydrochloride, monohydrate
|
|
3 | -4.94 |
| 53-802-2 |
Benzeneacetic acid, «alpha»-[[(trimethylsilyl)oxy]methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl ester, [7(S)-(1«alpha»,2«beta»,4«beta»,5«alpha»,7«beta»)]-
|
55373-83-6 |
3 | -2.60 |
| 54-652-8 |
7H-pyrrolo[2,3-d]pyrimidine, 4-amino-7-[3-(hydroxymethyl)cyclopentyl]-
|
|
3 | -2.83 |
| 55-862-4 |
5.beta.-Cholestane-3.alpha.,7.alpha.,26-triol, TMS
|
|
3 | -8.41 |
| 59-082-6 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)2
|
|
3 | -5.53 |
| 59-134-8 |
5-Androstene-3-«beta»,15-«alpha»,16-«alpha»,17-«beta»-tetrol, TMS
|
|
3 | -6.73 |
| 62-108-3 |
3-«alpha»,6-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
3 | -6.81 |
| 63-513-2 |
5«alpha»-Androstane-2«beta»,3«beta»,17«beta»-triol, TMS
|
|
3 | -6.85 |
| 66-948-7 |
1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole
|
|
3 | -4.52 |
| 68-784-7 |
3«alpha»,16«alpha»-dihydroxy-5«beta»-androstan-17-one, TMS
|
|
3 | -5.61 |
| 69-828-7 |
3-«alpha»,7-«alpha»-Dihydroxy-5-«beta»-cholestanoic acid, methyl ester, TMS
|
|
3 | -7.31 |
| 70-599-0 |
Androst-5-ene-3«beta»,16«beta»,17«beta»-triol, TMS
|
|
3 | -6.40 |
| 71-556-6 |
Pregn-4-ene-3,20-dione, 11,21-bis[(trimethylsilyl)oxy]-, bis(O-methyloxime), (11«beta»)-
|
32206-60-3 |
3 | -5.42 |
| 71-642-0 |
3«beta»,16«beta»,17«beta»-Tris(trimethylsiloxy)androst-5-ene
|
33287-31-9 |
3 | -6.40 |
| 73-388-1 |
1H-1,2,3-triazole-5-carboxamide, 4-amino-, compound with picric acid
|
|
3 | -3.80 |
| 74-009-0 |
Silane, dimethyl(dimethyl(2,3,5,6-tetrachlorophenoxy)silyloxy)(2,3,5,6-tetrachlorophenoxy)-
|
|
3 | -9.46 |
| 75-112-4 |
{P-[bis(2-hydroxyethyl)amino]benzyl}phosphonic acid, diethyl ester
|
16834-57-4 |
3 | -1.37 |
| 80-152-4 |
Androst-5-en-17-one, 3,16-bis[(trimethylsilyl)oxy]-, O-(trimethylsilyl)oxime, (3«beta»,16«beta»)-
|
69833-81-4 |
3 | -6.01 |
| 83-997-4 |
10-{3-[1-[2-(2-Hydroxyethoxy)ethyl]-4-piperazinyl]propyl}-2-trifluoromethyl-phenothiazine, dihydrochloride
|
|
3 | -5.19 |
| 84-534-6 |
17«beta»-Hydroxy-5«alpha»-androstane-3,6-dione, TMS
|
|
3 | -4.50 |
| 84-664-2 |
4-([(2E)-3,7-dimethyl-2,6-octadienyl]oxy)-7h-furo[3,2-g]chromen-7-one
|
|
3 | -5.94 |
| 84-752-4 |
Estra-1,3,5(10),6-tetraen-17-one, 3-[(trimethylsilyl)oxy]-
|
69688-26-2 |
3 | -5.27 |
| 87-324-6 |
Phenothiazine,10-[2-(1-methyl-4-piperazinyl)ethyl]-2-trifluoromethyl-, dihydrochloride
|
|
3 | -4.94 |
| 95-605-5 |
4-[3-(2-Trifluoromethyl-10-phenothiazinyl)propyl]-1-piperazineethanol, acetate, dihydrochloride
|
|
3 | -5.71 |
| 96-840-3 |
Butyramide, n-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-
|
|
3 | -2.93 |
| 97-309-2 |
19-Nor-17«alpha»-pregn-4-en-3-one, 17-(trimethylsiloxy)-
|
6689-89-0 |
3 | -5.08 |
| 98-716-9 |
Phosphorothiolo thionate, o,o-diethyl-s-(1-ethoxy-2-methylpropyl)-
|
|
3 | -4.68 |
| 99-930-0 |
6-[D-(2-amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
3 | -2.14 |
| 100-283-6 |
5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione
|
|
3 | -1.01 |
| 100-933-4 |
7-[(2-hydroxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
3 | -0.14 |
| 100-934-3 |
3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
3 | -2.62 |
| 101-819-0 |
2-(4-chloro-2-oxo-1,3-benzothiazol-3-yl)acetic acid
|
|
3 | -2.61 |
| 102-821-6 |
N-[2,2,2-trichloro-1-[4-(2,2,2-trichloro-1-formamidoethyl)piperazin-1-yl]ethyl]formamide
|
|
3 | -4.19 |
| 104-133-8 |
7-[(2-amino-2-cyclohexa-1,4-dien-1-ylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
3 | -1.22 |
| 105-690-9 |
1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
|
|
3 | -0.74 |
| 106-247-0 |
5-fluoro-1-[(4-methylphenyl)methyl]pyrimidine-2,4-dione
|
|
3 | -2.92 |
| 108-484-5 |
3-hydroxy-2-methyl-1-(4-methylphenyl)pyridin-4-one
|
|
3 | -3.22 |
| 108-577-2 |
1-[[4-(1,3-benzothiazol-2-yl)phenyl]methyl-ethoxyphosphoryl]pyrrolidin-2-one
|
|
3 | -3.73 |
| 109-237-8 |
5-fluoro-1-[(4-methoxyphenyl)methyl]pyrimidine-2,4-dione
|
|
3 | -2.75 |
| 109-314-2 |
1,3-dimethyl-5,5-diphenyl-1,3-diazinane-2,4,6-trione
|
|
3 | -4.20 |
| 109-670-7 |
3,3-dimethyl-7-oxo-6-[[2-(phenoxy)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
3 | -2.81 |
| 110-504-9 |
4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
|
|
3 | -2.95 |
| 111-365-3 |
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole
|
|
3 | -3.49 |
| 112-221-1 |
1,3,8-trimethyl-7-(2-methylpropyl)purine-2,6-dione
|
|
3 | -1.60 |
| 112-278-9 |
3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
3 | -1.62 |
| 113-309-3 |
2-Naphthaleneacetic acid, 6-methoxy-«alpha»-methyl-, trimethylsilyl ester, (+)-
|
|
3 | -4.40 |
| 113-944-8 |
Methyl 5-«beta»-cholan-7-«alpha»-ol-3-one-24-oate, oxime, TMS # 2
|
|
3 | -6.35 |
| 113-962-8 |
3«beta»,17,21«alpha»-Tris(trimethylsiloxy)pregn-5-ene
|
41164-19-6 |
3 | -6.55 |
| 114-271-4 |
6.alpha.-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, anti
|
|
3 | -5.09 |
| 115-936-5 |
3.alpha.-hydroxy-pregn-4-en-20-one, MO-TMS
|
|
3 | -5.31 |
| 116-555-7 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-PFP
|
|
3 | -7.48 |
| 120-304-0 |
1-Piperazine ethanol, 4-[3-(2-trifluoromethyl-10-phenoxazinyl)propyl]-, dihydrochloride
|
|
3 | -4.67 |
| 122-152-7 |
Methyl 5-«beta»-cholan-12-«alpha»-ol-3-one-24-oate, oxime, TMS # 1
|
|
3 | -6.44 |
| 122-958-3 |
Androst-4-ene-3.alpha.,17.beta.-diol , per-TMS
|
|
3 | -6.22 |
| 123-653-0 |
2,4-Pregnadien-(2,3-d)isoxazol-17.alpha.-ethynyl-17.beta.-ol, TMS
|
|
3 | -5.94 |
| 124-350-5 |
2-Chloro-10-(3'-dimethylaminopropyl)phenothiazine, 5-oxide, hydrochloride, monohydrate
|
|
3 | -5.01 |
| 124-647-6 |
Pregn-5-en-20-one, 3,16-bis[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,16«alpha»)-
|
57305-31-4 |
3 | -5.50 |
| 124-791-6 |
20.alpha.-hydroxy-pregn-4-en-3-one, MO-TMS, anti
|
|
3 | -5.67 |
| 54-928-2 |
5«alpha»-Androstane-2«alpha»,3«alpha»,17«beta»-triol, TMS
|
|
2 | -6.85 |
| 58-318-5 |
(2,4-Dichlorophenoxy) acetic acid, 2(2-aminoethoxy)ethanol salt
|
|
2 | -2.57 |
| 64-878-7 |
10-[3-(1-Methyl-4-piperazinyl)-2-methylpropyl]-2-trifluoromethylphenothiazine, dihydrochloride
|
|
2 | -5.53 |
| 78-171-6 |
9H-purine, 6-(methylthio)-9-beta-d-ribofuranosyl-, 5'-barium phosphate, hydrated
|
|
2 | -2.64 |
| 95-810-7 |
2-P-methoxyphenyl-3-phenylacrylic acid, 3-tropanyl ester, hydrochloride
|
6701-70-8 |
2 | -4.45 |
| 96-149-1 |
Ethanamine, 2-hydroxy-2-(m-hydroxyphenyl)-n-methyl-, 2-hydroxy-3-phenyl benzoic acid salt
|
|
2 | -2.31 |
| 96-339-0 |
Phenothiazine,10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, 5-oxide, dihydrochloride, hydrate
|
|
2 | -4.92 |
| 115-079-7 |
Cholanic acid, 3.alpha.,6.alpha.,7.alpha.-trihydroxy, Me-DMES
|
|
2 | -7.13 |
| 116-022-8 |
N-(beta-cyclohexyl-beta-hydroxy-beta-phenyl-ethyl)-n'-methylpiperazine methosulfate
|
|
2 | -2.73 |
| 118-469-1 |
Zinc 1,1-dioxo-1,2-benzothiazol-2-id-3-one hydrate
|
|
2 | -4.31 |
| 119-361-9 |
1-Phenylcyclopentanecarboxylic acid, 2-diethyl-aminoethyl ester, 1,2-ethanedisulfonate
|
|
2 | -7.20 |
| 119-611-1 |
2-Propanol, 1-tert-butylamino-3-(6-chloro-m-tolyloxy)-, hydrochloride
|
15148-80-8 |
2 | -2.83 |
| 120-958-5 |
Methyl 5-.beta.-cholan-12-.alpha.-ol-3-one-24-oate, oxime, TMS # 2
|
|
2 | -6.45 |
| 121-057-4 |
2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3, 6,11-trimethyl-, hydrochloride, monohydrate
|
|
2 | -2.57 |
| 122-275-1 |
Methyl 5-.beta.-cholan-7-.alpha.-ol-3-one-24-oate, oxime, TMS # 1
|
|
2 | -6.53 |
| 125-252-3 |
Pregn-4-en-17-ol, 3,20-bis[(trimethylsilyl)oxy]-, (3.beta.,20S)-
|
|
2 | -5.45 |
| 33-431-6 |
Indol-2(3h)-one, 3-(2-benzylamino)ethyl-3-phenyl-, hydrochloride
|
|
1 | -4.27 |
| 73-699-6 |
Thiaxanthene, 9-(3-dimethylaminopropyl)-2-triflluoromethyl-,maleate (1 to 1)
|
|
1 | -5.72 |
|
« Previous Results
|